#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Search results: (10000)



Journal articles Balance disorders in patients with multiple sclerosis and possible rehabilitation therapy – current findings from controlled clinical trials

Author of the article: K. Novotná-, I. Menkyová, M. Janatová Source: Česká a slovenská neurologie a neurochirurgie | 2/2022 15. 5. 2022

News The Brain, Too, Has Its Midlife Crisis. How Do These Changes Relate to the Risk of Dementia in Old Age?

The human brain undergoes rapid changes during certain developmental periods. Childhood, adolescence, and advanced old age undoubtedly belong to these. For much of adulthood, it seems that nothing much actually happens. However, it turns out that the brain’s clock begins to accelerate around 40–50 years of age. What impact do these gradual changes have on our future health?
Source: 31. 10. 2024

Journal articles A new definition of status epilepticus and its pharmacological management

Author of the article: O. Strýček, V. Šrámek Source: Anesteziologie a intenzivní medicína | 4/2018 24. 9. 2018

News Venotonics in Hemorrhoid Therapy – Results of a Systematic Review

Hemorrhoids are among the most common pathological findings in the anorectal area, and their incidence increases with age. Various modalities are used in the treatment of this condition, which has unpleasant health and psychological complications, aiming to alleviate the symptoms. Widely used and very popular are so-called venotonics, a large group of drugs and dietary supplements, mostly of natural origin, including diosmin.
Source: Venous Insufficiency 27. 3. 2020

News How to Determine the Optimal Target Value of Intraocular Pressure in Glaucoma Treatment?

Glaucoma remains the second most common cause of blindness in Europe. Therapy needs to be individualized with regard to the severity of the condition, expected lifespan, and the rate of disease progression. Which factors should we consider when determining the optimal target value of intraocular pressure (IOP) for a particular patient?
Source: Treatment of Glaucoma 8. 9. 2023

News Targeting HER2 is Clinically Meaningful Even with Its Low Expression

Distinguishing HER2 receptor expression status on the surface of breast cancer tumor cells as simply positive or negative is now proving insufficient. Ultimately, it can lead to the non-administration of effective targeted therapy. What do we actually know about the “gray zone” between HER2 positivity and negativity?
Source: Ovarian and Breast Cancer 22. 5. 2024

Journal articles Hand osteoarthritis

Author of the article: prof. MUDr. Ph.D. Ladislav Šenolt Source: Časopis lékařů českých | 6/2016 9. 11. 2016

News Impact of erdostein on bacterial biofilm − and what it means for clinical practice?

One of the substances that could potentially influence the success of treatments for infections associated with biofilm formation in the future is erdostein. This medication is used in the treatment of both acute and chronic diseases of the respiratory system (including chronic obstructive pulmonary disease) usually accompanied by increased mucus production. Its effect is mediated by several mechanisms that can also affect bacterial biofilm.
Source: Cough Therapy 28. 11. 2023

News Recommend Erdostein for children when treating with amoxicillin – symptoms of cough improve in almost 50% of cases within 3 days

Acute respiratory infections are usually treated empirically in primary care as the causative agent is not known. Amoxicillin is among the most commonly chosen antibiotics. Erdostein is a suitable addition to this antibiotic treatment for several reasons.
Source: Cough Therapy 19. 1. 2021

News What a General Practitioner Needs to Know About Gliflozins

The revolutionary benefits of gliflozins have completely changed the perspective on the choice of pharmacotherapy for diabetes. They have attracted not only diabetologists but also cardiologists and nephrologists after the favorable effects of this group of drugs on heart failure and renal functions were demonstrated even in patients without diabetes. Dapagliflozin and empagliflozin were subsequently included in recommendations for the treatment of heart failure regardless of the presence of diabetes. Dapagliflozin has also been approved for the treatment of patients with chronic kidney disease.
Source: Diabetes 22. 3. 2023

News Effect of Nuclear Magnetic Resonance Therapy in Patients with Osteoarthritis

Osteoarthritis represents the most common joint disease in adults, with its incidence and prevalence increasing with age. With the overall aging of the population, it is becoming a significant medical as well as social problem. Due to the growing number of cases, new modalities are being sought for current therapeutic procedures, including nuclear magnetic resonance therapy, whose effect has been verified by an extensive clinical study.
Source: Treatment of the Musculoskeletal System 21. 2. 2020

News Pain Management After Day Surgery

Effective pain control is a crucial part of recovery for patients after painful surgical procedures. In clinical practice, combined analgesia using paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs) is commonly utilized, which, however, is not suitable for up to a quarter of patients. An alternative could be metamizole. A study published in the European Journal of Anaesthesiology evaluated the non-inferiority of the combination of paracetamol/metamizole versus paracetamol/ibuprofen in pain management for patients after day surgery.
Source: Analgesia 21. 4. 2022

News Ocrelizumab in the Treatment of Multiple Sclerosis – 10-Year Data

Multiple sclerosis (MS) is a lifelong disease with a high risk of permanent disability. Current information on the long-term efficacy and safety of treatment is therefore absolutely essential for the optimal choice of therapeutic agent – in this case, ocrelizumab.
Source: Neurology - Multiple Sclerosis 20. 2. 2024

News Metformin in Pregnancy and Its Safety Profile

In Finland, a comprehensive analysis of data from the national registry was conducted to assess whether exposure to metformin during intrauterine development is associated with an increased risk of long-term or short-term health problems.
Source: Modern Treatment of Diabetes 6. 6. 2022

News Metamizole – wide possibilities of an analgesic with a unique mechanism of action and different routes of administration

Metamizole is a non-addictive pyrazolone analgesic with antipyretic effects, which differs from other non-opioid analgesics by its spasmolytic action. It is indicated in monotherapy and in combinations for the treatment of severe acute and chronic pain. Its high analgesic efficacy is evidenced by a low number of patients needed to treat to achieve at least 50% pain relief in 4-6 hours. The favorable safety profile of metamizole is supported by more than 100 years of clinical experience.
Source: Analgesia 30. 5. 2024

News Quo vadis, erdostein? Or the current and future potential of erdosteine in practice

Erdosteine has a well-established place in the therapy of acute respiratory diseases in children. Its mucolytic and antibacterial properties are very well documented. Recently, research has focused primarily on the anti-inflammatory and antioxidant effects of this molecule. Attention is also being paid to its antiviral potential. How does it stand in this regard?
Source: Cough Therapy 15. 2. 2022

News Diosmin and Hesperidin: What Does Pharmacokinetics Show?

Flavonoids are plant-derived compounds that have a number of beneficial pharmacological effects. Among the most well-known flavonoids, alongside rutin, are diosmin and hesperidin, which are used as venotonics and vasoprotectives in chronic venous insufficiency (CVI).
Source: Venous Insufficiency 23. 4. 2020

Journal articles Depression in Selected Neurological Disorders

Author of the article: I. Štětkářová, J. Horáček Source: Česká a slovenská neurologie a neurochirurgie | 6/2016 10. 11. 2016

News Trazodone as an Effective Medicine in the Therapy of Depression and Insomnia

Trazodone (Trittico®) is a medicine indicated for the treatment of depression, which has also been shown to have a positive effect in treating other associated conditions. In practice, however, the potential of its multimodal effect sometimes remains untapped.
Source: Depression and Anxiety 19. 7. 2020

News Current Therapy Options for Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis is a chronic progressive disease that exclusively affects adults, predominantly of middle and older age. Until recently, the disease was practically untreatable. However, this has changed with the discovery of antifibrotic drugs, which have significantly altered the prognosis for patients. Early diagnosis and initiation of therapy at a specialized center, of which there are several in the Czech Republic, are essential for success.
Source: Pulmonary Fibrosis 4. 6. 2020

News Electronic Cigarettes as an Alternative Option for Quitting Smoking?

Diseases caused by smoking tobacco products are a significant cause of global morbidity and mortality. One of the options for quitting smoking is electronic cigarettes, which, although not entirely researched yet, according to available studies, genuinely help people quit smoking and are associated with significantly lower health risks compared to traditional tobacco products.
Source: MDT Board 12. 1. 2023

News Side Effects of Antipsychotics and Patient Preferences in the Treatment of Schizophrenia

Although a number of antipsychotics are currently available, many patients still suffer from unpleasant side effects associated with the treatment of schizophrenia. To determine how individuals with schizophrenia and schizoaffective disorders perceive antipsychotic treatment, a larger survey was conducted in the USA in 2016.
Source: Modern Treatment of Schizophrenia 9. 10. 2023

News Pitfalls of Levothyroxine Replacement Therapy

Hypothyroidism (reduced function of the thyroid gland) affects approximately 1-2% of the population. Its prevalence increases with age and it is more common in women. Synthetic thyroid hormone levothyroxine is used to treat hypothyroidism. It is a widely prescribed medication available in tablets of various strengths.
Source: Thyroid Disorders 8. 3. 2021

News Even a Single Epileptic Seizure is Too Much

Focal epileptic seizures resistant to pharmacotherapy represent an ongoing unmet medical need.
Source: Epilepsy 7. 4. 2022

News Position of Levodropropizine in Cough Therapy

An international group of specialists focused in 2016–2017 on a detailed evaluation of current options for cough therapy. The authors based their analysis on individually prepared reviews using Medline and Embase databases, and they presented their work's results last year in the journal Pulmonary Pharmacology & Therapeutics.
Source: Cough Therapy 15. 1. 2020

1 63 64 65 66 67 400
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#